NDC 11523-7202-01 - Claritin Reditabs
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11523-7202
- Requested NDC
- 11523-7202-01
- Package NDCs from labels
- 11523-7202-1, 11523-7202-3, 11523-7202-01
- Manufacturer
- Bayer HealthCare LLC
- Effective date
- 2025-12-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Claritin Reditabs - Bayer HealthCare LLC | Bayer HealthCare LLC | 2025-12-05 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11523-7202-1 | ClaritinReditabs | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | 12 | |
| 11523-7202-1 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7202-3 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7202-3 | ClaritinReditabs | 1 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 1 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11523-7202 | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [BAYER HEALTHCARE LLC] | 11 | Current NDC, Legacy NDC, 4 package rows | 20241208_7dc04b48-f053-4e4b-a493-9e8286d2a791.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 11523-7202-1 | EA - Each | 11523-7202 | 2d9569c3-1d2b-4a96-a48f-54e4ce505bd9 | 1 | 2012-07-24 |
| 11523-7202-3 | EA - Each | 11523-7202 | 8c62db1c-bc79-4bd8-aae5-46837fb33bf9 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Loratadine | ACTIVE INGREDIENT | 7AJO3BO7QN | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| Loratadine | ACTIVE MOIETY | 7AJO3BO7QN | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| gelatin | INACTIVE INGREDIENT | 2G86QN327L | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| allergy relief d 12 | LORATADINE, PSEUDOEPHEDRINE SULFATE | Walgreen Company | 7e6ea563-cc79-4683-b600-0691e0fb78ab | 2026-04-09 | Warnings | 7AJO3BO7QN |
| Childrens Loratadine | LORATADINE | Sun Pharmaceutical Industries, Inc. | 78e11f1c-c8a4-4b2a-b7dc-ae1b2dea26d0 | 2026-04-08 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | NuCare Pharmaceuticals,Inc. | 16f00a3a-0777-f70c-e063-6294a90a71c9 | 2026-04-06 | Warnings | 7AJO3BO7QN |
| ALLERGY RELIEF 10 mg | LORATADINE | TWIN MED LLC | d943f548-aa0d-4476-e053-2a95a90a7bd4 | 2026-04-01 | Warnings | 7AJO3BO7QN |
| ALLERGY RELIEF | LORATADINE | CARDINAL HEALTH 110, LLC. DBA LEADER | 052e0ea2-441f-42cc-b62c-f2574f995bff | 2026-03-31 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | Safecor Health, LLC | 14d1ecf5-d694-4ce0-87e4-df27f3f4d909 | 2026-03-31 | Warnings | 7AJO3BO7QN |
| LORATADINE | LORATADINE | CVS HEALTH CORP | 899800a7-89bc-4a39-88b0-f19d78934daf | 2026-03-26 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | CVS Pharmacy, Inc. | 3937f769-e8e2-4b32-8338-21b0a74a8697 | 2026-03-20 | Warnings | 7AJO3BO7QN |
| Loratadine Allergy Relief | LORATADINE | PD-Rx Pharmaceuticals, Inc. | 7127b39d-3686-4249-b720-43c02b4c4654 | 2026-03-19 | Warnings | 7AJO3BO7QN |
| Childrens Loratadine Oral | LORATADINE | A-S Medication Solutions | 0a42baae-554b-4b93-8780-fe45c42fabc0 | 2026-03-18 | Warnings | 7AJO3BO7QN |
| CHILDRENS ALLERGY RELIEF | LORATADINE | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 0e84571d-87b6-4742-ac62-9ed68a115c72 | 2026-03-17 | Warnings | 7AJO3BO7QN |
| allergy relief d 12 | LORATADINE, PSEUDOEPHEDRINE SULFATE | CVS Pharmacy | 0ca2b074-7137-478c-b32c-67f834f6c454 | 2026-03-15 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | NuCare Pharmaceuticals,Inc. | c0e3057d-2dd2-de2b-e053-2995a90a1a1d | 2026-03-05 | Warnings | 7AJO3BO7QN |
| Allergy Relief D | LORATADINE, PSEUDOEPHEDRINE SULFATE | Walgreen Company | 9952e0fb-b20e-4f9c-8be7-aa286e271fee | 2026-02-28 | Warnings | 7AJO3BO7QN |
| Loratadine antihistamine | LORATADINE | PD-Rx Pharmaceuticals, Inc. | 039f144b-891b-4ab0-e063-6394a90aa4c8 | 2026-02-26 | Warnings | 7AJO3BO7QN |
| Loratadine antihistamine | LORATADINE | PD-Rx Pharmaceuticals, Inc. | 775885f9-0580-4eca-94d8-44fce1dcdccd | 2026-02-26 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | ATLANTIC BIOLOGICALS CORP. | 999a1080-5bbd-4027-b6e7-a90a6941ee27 | 2026-02-26 | Warnings | 7AJO3BO7QN |
| Dr Simi All Day Allergy Relief | LORATADINE | Farmacias De Similares TX LLC | 3c5b2eaa-24da-3314-e063-6294a90a5b21 | 2026-02-26 | Warnings | 7AJO3BO7QN |
| Kidnex IV | GINKGO BILOBA, ALPHA-KETOGLUTARICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MALICUM ACIDUM, PYRUVIC ACID, SUCCINICUM ACIDUM, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, GERMANIUM SESQUIOXIDE, MERCURIUS VIVUS, NUX VOMICA, KIDNEY (SUIS), LYMPH NODE (SUIS), NAPHTHOCHINONUM, NATRUM OXALACETICUM, PHOSPHORUS, URINARY BLADDER (SUIS), ACONITICUM ACIDUM, CIS- | Energique, Inc. | 23de6b8e-7622-4ba6-89f7-37bd151687e2 | 2026-02-26 | Warnings | XF417D3PSL |
| Leader Extra Strength Effervescent Antacid and Pain Reliever | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Cardinal Health | c5d7bf5f-3e59-52f2-e053-2a95a90a4a00 | 2026-02-25 | Warnings | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.